Encompass Health Investor News: Investigation into Potential Securities Claims - EHC

Encompass Health Corporation is under investigation for potentially issuing misleading business information to investors. The investigation is related to a New York Times article that found some Encompass Health rehab hospitals had rare but serious incidents of patient harm and performed below average on safety measures tracked by Medicare. The price of Encompass Health stock fell 10.3% after the article was published. Investors may be entitled to compensation through a contingency fee arrangement.

Encompass Health Corporation (NYSE: EHC) is currently under investigation for potentially misleading investors with inaccurate business information. The probe is connected to a New York Times article published on July 15, 2025, which revealed that certain Encompass Health rehab hospitals had serious incidents of patient harm and performed below average on key safety measures tracked by Medicare. Following the article's publication, Encompass Health's stock price fell by 10.3%.

The Rosen Law Firm and Pomerantz LLP have both initiated investigations on behalf of Encompass Health shareholders. According to Rosen Law Firm, investors who purchased Encompass Health securities may be eligible for compensation through a class action lawsuit. The firm encourages investors to contact them at [1] https://rosenlegal.com/submit-form/?case_id=44051 or call toll-free at 866-767-3653. Pomerantz LLP is also investigating claims and advises investors to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980 [2].

The New York Times article highlighted that Encompass Health owns many rehab facilities with worse rates of potentially preventable, unplanned readmissions to general hospitals. It also reported several "alarming mistakes" that led to patient fatalities in Encompass-owned facilities. The investigation into Encompass Health's business practices is ongoing, and investors are urged to stay informed and take appropriate action.

References:
[1] https://www.morningstar.com/news/pr-newswire/20250827dc60621/encompass-health-investor-news-rosen-law-firm-encourages-encompass-health-corporation-investors-to-inquire-about-securities-class-action-investigation-ehc
[2] https://www.marketscreener.com/news/pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-encompass-health-corporation-ehc-ce7c50dedf8ff520